Marie Abdallah, MD

After completing her medical school education in Lebanon, Dr. Abdallah received her residency training at Staten Island University Hospital and her Infectious Diseases fellowship training at SUNY Downstate. She remained at NYC Health+Hospitals/Kings County, and in 2015 became Director of HIV Services. Dr. Abdallah is an Assistant Professor of Medicine and the Associate Program Director for the Division of Infectious Diseases. She is in charge of the Infectious Diseases, Travel, Sexual Health, and Center for Hope clinics at NYC H+H/Kings County. Her professional and research interests involve sexually transmitted infections, HIV, epidemiology of Infectious Diseases.

Research Interests:

STI, Antibiotic-Resistant Gonorrhea, syphilis, HIV

Education and Training:

• Medical School: Lebanese University - faculty of medical sciences
• Internal Medicine Residency: Staten Island University Hospital, NY
• Infectious Diseases fellowship: SUNY Downstate Medical Center

Why I enjoy working at SUNY Downstate:

SUNY Downstate and the Kings County Hospital Center are exciting places to work. I enjoy the exposure to a diverse population from all over the world, the complexity of cases, interesting pathology. The opportunities for teaching, and work with students and fellows keep me energized. Along with the great clinical experience, we have an unlimited opportunity for research.

• Abdallah M, Olafisoye O, Cortes C, Urban C, Charles C, Landman D, Quale J. Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City. Am J Infect Cont 2015; In Press.
• Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Quale J. Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City. Antimicrob Agents Chemother 2015 ; 59: 1802-5.
• Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Quale J, Landman D. Activity of meropenem combined with RPX7009, a novel β-lactamase inhibitor, against Gram-negative clinical isolates in New York City. Antimicrob Agents Chemother. 2015 Jun 1. pii: AAC.00843-15.
• Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Landman D, Quale J. Activity of imipenem with relebactam against Gram negative pathogens from New York City. Antimicrob Agents Chemother. 2015 May 26. pii: AAC.00830-15.